Other studies also demonstrated that mice models for psoriasis are ameliorated by interfering angiogenesis by recombinant disintegrin domain of ADAM-15 [14] and pigment epithelium-derived factor [15], suggesting that angiogenesis is a possible therapeutic target of psoriasis. This evidence concerns the gene ADAM15 and psoriasis.